Health Canada is working to identify lab capacity across the country to assist with COVID-19 testing, and the agency has reached out to certain federal cannabis license holders, Marijuana Business Daily has learned.

Canada is currently experiencing a testing backlog for COVID-19.

In Ontario alone, 10,965 people have test coronavirus results pending.

In a message to licensed cannabis researchers and labs Thursday afternoon, the federal health department said it is working to understand “the needs and related questions.”

“If you have lab capacity within your facility and are interested in assisting, please notify us by email,” Health Canada asked in its own email, which says it was sent by Acting Director General Joanne Garrah.

As of mid-March, there were 272 active cannabis research licenses in Canada plus 111 analytical testing licensees.

John Coleman, president of British Columbia-based Anandia, confirmed the authenticity of the email.

Coleman said Anandia will help in any way that is possible to support the effort, but he needs to see details about what exactly is needed from a testing perspective.

“The hope here is that we can all band together and do what we can to help stem this,” he told MJBizDaily.

Anandia is a wholly owned subsidiary of Aurora Cannabis operating independently.

Health Canada did not immediately return queries from MJBizDaily.

Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto. He can be reached at [email protected].

For more of Marijuana Business Daily’s ongoing coverage of the coronavirus pandemic and its effects on the cannabis industry, click here.

Pure Cannabis Hemp Oil

• Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

• Clinically proven therapeutic effects.

• Relieves anxiety and stress

• Eliminates chronic pain and aches

• Regulates mood and sleep patterns

• Enhances focus and clarity
  
  
  

addiitional information, George Scorsis
Originally posted on via Cannabis Industry News